My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 400

    1.

    Prostate-specific antigen screening: pro.

    Loeb S, Catalona WJ.

    Curr Opin Urol. 2010 Mar 10. [Epub ahead of print]PMID: 20224413 [PubMed - as supplied by publisher]Related articles

    2.

    Risk Factors for Prostate Cancer Detection After a Negative Biopsy: A Novel Multivariable Longitudinal Approach.

    Gann PH, Fought A, Deaton R, Catalona WJ, Vonesh E.

    J Clin Oncol. 2010 Feb 22. [Epub ahead of print]PMID: 20177031 [PubMed - as supplied by publisher]Related articles

    3.

    [-2]Proenzyme Prostate Specific Antigen is More Accurate Than Total and Free Prostate Specific Antigen in Differentiating Prostate Cancer From Benign Disease in a Prospective Prostate Cancer Screening Study.

    Le BV, Griffin CR, Loeb S, Carvalhal GF, Kan D, Baumann NA, Catalona WJ.

    J Urol. 2010 Feb 18. [Epub ahead of print]PMID: 20171670 [PubMed - as supplied by publisher]Related articles

    4.

    Prostate cancer screening and determining the appropriate prostate-specific antigen cutoff values.

    Catalona WJ, Loeb S.

    J Natl Compr Canc Netw. 2010 Feb;8(2):265-70.PMID: 20141681 [PubMed - in process]Related articles

    5.

    NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer Early Detection.

    Kawachi MH, Bahnson RR, Barry M, Busby JE, Carroll PR, Carter HB, Catalona WJ, Cookson MS, Epstein JI, Etzioni RB, Giri VN, Hemstreet GP 3rd, Howe RJ, Lange PH, Lilja H, Loughlin KR, Mohler J, Moul J, Nadler RB, Patterson SG, Presti JC, Stroup AM, Wake R, Wei JT.

    J Natl Compr Canc Netw. 2010 Feb;8(2):240-62. No abstract available. PMID: 20141680 [PubMed - in process]Related articles

    6.

    Treatment outcomes of radical prostatectomy in potential candidates for 3 published active surveillance protocols.

    Thaxton CS, Loeb S, Roehl KA, Kan D, Catalona WJ.

    Urology. 2010 Feb;75(2):414-8. Epub 2009 Dec 5.PMID: 19963249 [PubMed - in process]Related articles

    7.

    Can prostate specific antigen velocity thresholds decrease insignificant prostate cancer detection?

    Loeb S, Roehl KA, Helfand BT, Kan D, Catalona WJ.

    J Urol. 2010 Jan;183(1):112-6. Epub .PMID: 19913814 [PubMed - indexed for MEDLINE]Related articles

    8.

    Is statin use associated with prostate cancer aggressiveness?

    Loeb S, Kan D, Helfand BT, Nadler RB, Catalona WJ.

    BJU Int. 2009 Nov 3. [Epub ahead of print]PMID: 19888973 [PubMed - as supplied by publisher]Related articles

    9.

    Reducing blood loss in open radical retropubic prostatectomy with prophylactic periprostatic sutures.

    Carvalhal GF, Griffin CR, Kan D, Loeb S, Catalona WJ.

    BJU Int. 2009 Nov 3. [Epub ahead of print]PMID: 19888968 [PubMed - as supplied by publisher]Related articles

    10.

    Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.

    Gudmundsson J, Sulem P, Gudbjartsson DF, Blondal T, Gylfason A, Agnarsson BA, Benediktsdottir KR, Magnusdottir DN, Orlygsdottir G, Jakobsdottir M, Stacey SN, Sigurdsson A, Wahlfors T, Tammela T, Breyer JP, McReynolds KM, Bradley KM, Saez B, Godino J, Navarrete S, Fuertes F, Murillo L, Polo E, Aben KK, van Oort IM, Suarez BK, Helfand BT, Kan D, Zanon C, Frigge ML, Kristjansson K, Gulcher JR, Einarsson GV, Jonsson E, Catalona WJ, Mayordomo JI, Kiemeney LA, Smith JR, Schleutker J, Barkardottir RB, Kong A, Thorsteinsdottir U, Rafnar T, Stefansson K.

    Nat Genet. 2009 Oct;41(10):1122-6. Epub 2009 Sep 20.PMID: 19767754 [PubMed - indexed for MEDLINE]Related articles

    11.

    Editorial comment.

    Catalona WJ.

    J Urol. 2009 Nov;182(5):2278-9; discussion 2279. Epub 2009 Sep 16. No abstract available. PMID: 19758652 [PubMed - indexed for MEDLINE]Related articles

    12.

    Editorial comment.

    Catalona WJ.

    Urology. 2009 Sep;74(3):624-5. No abstract available. PMID: 19716918 [PubMed - indexed for MEDLINE]Related articles

    13.

    MEK4 function, genistein treatment, and invasion of human prostate cancer cells.

    Xu L, Ding Y, Catalona WJ, Yang XJ, Anderson WF, Jovanovic B, Wellman K, Killmer J, Huang X, Scheidt KA, Montgomery RB, Bergan RC.

    J Natl Cancer Inst. 2009 Aug 19;101(16):1141-55. Epub 2009 Jul 28.PMID: 19638505 [PubMed - indexed for MEDLINE]Related articles

    14.

    20-25% lower concentrations of total and free prostate-specific antigen (PSA) after calibration of PSA assays to the WHO reference materials--analysis of 1098 patients in four centers.

    Stephan C, Bangma C, Vignati G, Bartsch G, Lein M, Jung K, Philippe M, Semjonow A, Catalona WJ.

    Int J Biol Markers. 2009 Apr-Jun;24(2):65-9.PMID: 19634108 [PubMed - indexed for MEDLINE]Related articles

    15.

    Does diabetes mellitus modify the association between 17q12 risk variant and prostate cancer aggressiveness?

    Loeb S, Helfand BT, Kan D, Isaacs WB, Catalona WJ.

    BJU Int. 2009 Nov;104(9):1200-3. Epub 2009 Jul 20.PMID: 19627283 [PubMed - indexed for MEDLINE]Related articles

    16.

    Prostate-cancer screening.

    Catalona WJ.

    N Engl J Med. 2009 Jul 9;361(2):202; author reply 204-5. No abstract available. PMID: 19587348 [PubMed - indexed for MEDLINE]Related articles

    17.

    Bladder neck contracture after retropubic radical prostatectomy: incidence and risk factors from a large single-surgeon experience.

    Erickson BA, Meeks JJ, Roehl KA, Gonzalez CM, Catalona WJ.

    BJU Int. 2009 Dec;104(11):1615-9. Epub 2009 Jul 2.PMID: 19583720 [PubMed - indexed for MEDLINE]Related articles

    18.

    Common variants in 8q24 are associated with risk for prostate cancer and tumor aggressiveness in men of European ancestry.

    Pal P, Xi H, Guha S, Sun G, Helfand BT, Meeks JJ, Suarez BK, Catalona WJ, Deka R.

    Prostate. 2009 Oct 1;69(14):1548-56.PMID: 19562729 [PubMed - indexed for MEDLINE]Related articles

    19.

    Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.

    Zhang Q, Helfand BT, Jang TL, Zhu LJ, Chen L, Yang XJ, Kozlowski J, Smith N, Kundu SD, Yang G, Raji AA, Javonovic B, Pins M, Lindholm P, Guo Y, Catalona WJ, Lee C.

    Clin Cancer Res. 2009 May 15;15(10):3557-67. Epub 2009 May 15.PMID: 19447876 [PubMed - indexed for MEDLINE]Related articles

    20.

    Pathological outcomes associated with the 17q prostate cancer risk variants.

    Helfand BT, Loeb S, Meeks JJ, Fought AJ, Kan D, Catalona WJ.

    J Urol. 2009 Jun;181(6):2502-7. Epub 2009 Apr 16.PMID: 19371897 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...
    Write to the Help Desk